Alessandro Rambaldi to Hypereosinophilic Syndrome
This is a "connection" page, showing publications Alessandro Rambaldi has written about Hypereosinophilic Syndrome.
Connection Strength
0.098
-
A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes. Br J Haematol. 2009 Dec; 147(5):681-5.
Score: 0.098
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.